Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer

Xin Jin, Qing Yang, Youwen Zhang Department of Hospital Pharmacy, Suqian Branch Jiangsu Province Hospital, Suzhilu, Suqian, People’s Republic of China Abstract: To develop an alternative treatment for lung cancer, a combination of two potent chemotherapeutic agents – liposomal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jin X, Yang Q, Zhang Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/b70aead511984e2295491a84d1ca71e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b70aead511984e2295491a84d1ca71e8
record_format dspace
spelling oai:doaj.org-article:b70aead511984e2295491a84d1ca71e82021-12-02T08:07:44ZSynergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer1178-2013https://doaj.org/article/b70aead511984e2295491a84d1ca71e82017-07-01T00:00:00Zhttps://www.dovepress.com/synergistic-apoptotic-effects-of-apigenin-tpgs-liposomes-and-tyroserva-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xin Jin, Qing Yang, Youwen Zhang Department of Hospital Pharmacy, Suqian Branch Jiangsu Province Hospital, Suzhilu, Suqian, People’s Republic of China Abstract: To develop an alternative treatment for lung cancer, a combination of two potent chemotherapeutic agents – liposomal apigenin and tyroservatide – was developed. The therapeutic potential of this combination was investigated using A549 cells. Apigenin and tocopherol derivative-containing D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) liposomes might improve the delivery of apigenin to tumor cells, both in vitro and in vivo. Importantly, compared to either agent alone, the combination of apigenin TPGS liposomes and tyroservatide exhibited superior cytotoxicity, induced stronger G2 arrest, and suppressed A549 cancer cell invasion at a lower dose. The proapoptotic synergistic effects were also observed in A549 cells using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling, flow cytometry, and Western blot analysis. More importantly, in vivo results showed that the combination of apigenin TPGS liposomes and tyroservatide exhibited tumor-growth inhibitory effects in A549 cell-bearing mice. In conclusion, our study showed that this combination therapy could serve as a promising synergistic therapeutic approach to improve outcomes in patients with lung cancer. Keywords: apigenin, TPGS liposomes, tyroservatide, synergistic antitumor, apoptosis Jin XYang QZhang YDove Medical PressarticleapigeninTPGS liposomestyroservatidesynergistic anti-tumorapoptosisMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 5109-5118 (2017)
institution DOAJ
collection DOAJ
language EN
topic apigenin
TPGS liposomes
tyroservatide
synergistic anti-tumor
apoptosis
Medicine (General)
R5-920
spellingShingle apigenin
TPGS liposomes
tyroservatide
synergistic anti-tumor
apoptosis
Medicine (General)
R5-920
Jin X
Yang Q
Zhang Y
Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer
description Xin Jin, Qing Yang, Youwen Zhang Department of Hospital Pharmacy, Suqian Branch Jiangsu Province Hospital, Suzhilu, Suqian, People’s Republic of China Abstract: To develop an alternative treatment for lung cancer, a combination of two potent chemotherapeutic agents – liposomal apigenin and tyroservatide – was developed. The therapeutic potential of this combination was investigated using A549 cells. Apigenin and tocopherol derivative-containing D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) liposomes might improve the delivery of apigenin to tumor cells, both in vitro and in vivo. Importantly, compared to either agent alone, the combination of apigenin TPGS liposomes and tyroservatide exhibited superior cytotoxicity, induced stronger G2 arrest, and suppressed A549 cancer cell invasion at a lower dose. The proapoptotic synergistic effects were also observed in A549 cells using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling, flow cytometry, and Western blot analysis. More importantly, in vivo results showed that the combination of apigenin TPGS liposomes and tyroservatide exhibited tumor-growth inhibitory effects in A549 cell-bearing mice. In conclusion, our study showed that this combination therapy could serve as a promising synergistic therapeutic approach to improve outcomes in patients with lung cancer. Keywords: apigenin, TPGS liposomes, tyroservatide, synergistic antitumor, apoptosis 
format article
author Jin X
Yang Q
Zhang Y
author_facet Jin X
Yang Q
Zhang Y
author_sort Jin X
title Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer
title_short Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer
title_full Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer
title_fullStr Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer
title_full_unstemmed Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer
title_sort synergistic apoptotic effects of apigenin tpgs liposomes and tyroservatide: implications for effective treatment of lung cancer
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/b70aead511984e2295491a84d1ca71e8
work_keys_str_mv AT jinx synergisticapoptoticeffectsofapigenintpgsliposomesandtyroservatideimplicationsforeffectivetreatmentoflungcancer
AT yangq synergisticapoptoticeffectsofapigenintpgsliposomesandtyroservatideimplicationsforeffectivetreatmentoflungcancer
AT zhangy synergisticapoptoticeffectsofapigenintpgsliposomesandtyroservatideimplicationsforeffectivetreatmentoflungcancer
_version_ 1718398682590609408